Ellen AB

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0014730347
SEK
0.77
0.03 (3.36%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Ellen AB stock-summary
stock-summary
Ellen AB
Pharmaceuticals & Biotechnology
Ellen AB is a Sweden-based biotechnology company that produces probiotic sanitary protection products for women. The Company’s main product, Ellen tampon, contains patented natural lacto acid bacteria, Lacto Naturel (LN), and is used for maintaining the vaginal health. The Ellen tampon is made of natural fibers treated with the substance LN, which consists of human lactic acid bacteria, a natural part of healthy women's defense against infections. Ellen AB distributes its products in 37 countries, including Scandinavian countries, France, Germany, Czech Republic, Spain, Portugal, Poland and Belgium, among others. As of December 31, 2011, the Company had two subsidiaries, including the wholly owned Ellen Australia pty LTD and the 70%-owned Ellen Asia LTD. As of December 31, 2011, its largest shareholder was Banque Ohman S.A. (18.73%). On July 3, 2013, it launched an online store, www.ellen.se, where customers can search for products' information and shop online.
Company Coordinates stock-summary
Company Details
Barnhusgatan 4 og bv , STOCKHOLM None : 111 23
stock-summary
Tel: 46 8 4121000
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Jens Engstrom
Chairman of the Board
Mr. Mikael Lovgren
Director
Ms. Catharina Skommevik
Director
Ms. Catarina Vackholt
Director
Ms. Cecilia Wolf
Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
2 Million
(Quarterly Results - Dec 2013)
Net Profit:
-2 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 10 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.14

stock-summary
Return on Equity

-169.99%

stock-summary
Price to Book

2.93